Position
Parallel Advisors, LLC in Edgewise Therapeutics, Inc.
Back to the book · All holders of EWTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.18K$24.81 → $31.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 626 | $15.5K | — | — | — | 0.0% |
| Q1 2026 | 1.03K | $32.5K | $31.50 | $4.18K | $12.8K | 0.0% |